Severe fever with thrombocytopenia syndrome (SFTS) is a life-threatening infectious disease characterized by high mortality and severe thrombocytopenia. The main cause of this condition is a virus belonging to the flavivirus family, which is transmitted through the bites of infected blood-sucking insects such as mosquitoes and ticks. The clinical course of the disease can vary from severe fever and shock to severe hemostatic disorders, which requires close medical supervision and active intervention. A study of SFTS revealed a relationship between platelet levels and the severity of clinical symptoms, which makes it important to understand the pathogenesis and mechanisms of this disease.
History of the disease and interesting historical facts
The history of severe fever with thrombocytopenia syndrome dates back to the early 20th century, when the first cases of the disease caused by a severe influx of a virus that was later isolated and named TFTS virus were described in China in 1944. Interestingly, in 2000, an outbreak in Southeast Asia resulted in a significant increase in cases, leading to increased attention from international health organizations. Importantly, the virus was found not only in Asian countries, but also in parts of Europe. This led to a revision of diagnostic and treatment regimens, as well as the development of new vaccines and infection control guidelines.
Epidemiology
The epidemiology of TLST shows significant variability depending on the geographical location and environmental conditions. According to the World Health Organization, in recent years there has been an increase in cases, especially in tropical and subtropical regions such as Southeast Asia, South America and Central Africa. Statistics show that the incidence in some countries can reach 20 cases per 100,000 population, which necessitates the development of effective monitoring and prevention programs. In addition, in the context of globalization and climate change, further spread of the disease to new regions can be expected, which increases the relevance of its study.
Genetic predisposition to this disease
Currently, genetic factors that may contribute to the development of severe fever with thrombocytopenia syndrome are being studied. Numerous scientific papers point to certain polymorphisms of genes responsible for the immune response, such as the TNF-α and IL-6 genes, which may play a role in the predisposition of the body to infections. Mutations or variations in these genes may affect the relative susceptibility to the virus, the level of production of proinflammatory cytokines and, accordingly, the severity of the disease. These factors emphasize the importance of an individual approach to the treatment and prevention of TLST, as well as the need for additional study of the variability of genetic markers among different populations.
Risk factors for the development of this disease
Among the risk factors that contribute to the development of TLST, both physical and chemical are distinguished. The key ones include:
- Bites from mosquitoes and other blood-sucking insects.
- Living in regions where the disease is endemic.
- Insufficient preventive measures such as the use of repellents.
- Working in or visiting rural and wooded areas where carriers of the infection are active.
Other possible factors, such as immunosuppression, previous viral infections, and the presence of chronic diseases, are also noted, which may increase susceptibility to the virus and worsen disease outcomes.
Diagnosis of this disease
Diagnosis of severe fever with thrombocytopenia syndrome involves a wide range of methods aimed at determining both clinical and laboratory signs. Initial symptoms may include:
- High fever.
- Nausea and vomiting.
- Pain in muscles and joints.
- Skin rashes and bleeding.
Laboratory investigations performed when TLST is suspected include a complete blood count with platelet count, serologic testing for the virus and its antigens. Radiologic examinations may be useful to evaluate the organs, especially if hemorrhagic manifestations are present. Differential diagnosis requires consideration of other infectious diseases with similar clinical manifestations, such as dengue, West Nile fever, and other tropical infections.
Treatment
Treatment of TLST is complex and requires a multidisciplinary approach. In general, depending on the severity of the condition, treatment may include:
- Supportive therapy (we are talking about hydration and correction of electrolyte balance).
- Pharmacological therapy aimed at reducing intoxication (for example, paracetamol to control temperature).
- Hemotherapy in cases of significant thrombocytopenia (platelet transfusion).
- Immunotherapy for severe forms, which can be supplemented by the use of interferons.
Surgical intervention may be necessary if full-blown hemorrhagic shock or other serious complications such as mechanical vascular occlusion occur.
List of medications used to treat this disease
The main drugs used to treat TLST include:
- Paracetamol (to reduce fever).
- Corticosteroids (to reduce the inflammatory response).
- Immunoglobulins (if necessary to correct the immune response).
- Broad-spectrum antibiotics (to prevent secondary infections).
These drugs can be prescribed taking into account the severity class of the disease and the general condition of the patient.
Disease monitoring
Monitoring of TLST disease includes regular clinical and laboratory tests to assess the dynamics of the patient's condition. Control stages include:
- Daily temperature measurement.
- Complete blood count (CBC) testing to monitor platelet levels.
- Evaluation of clinical manifestations such as the presence of hematomas and bleeding.
- Prediction of cumulative data analysis to determine the risk of complications.
The prognosis of the disease depends on the timeliness and correctness of treatment, but in the absence of adequate care it can lead to serious complications, including hemorrhagic shock, organ failure and high mortality.
Age-related features of the disease
Severe fever with thrombocytopenia syndrome may manifest itself with different symptoms in patients of different age groups. In children, the disease usually occurs in a severe form with pronounced hemorrhagic manifestations. In the elderly, atypical symptoms are often observed: exacerbations of concomitant diseases and a higher probability of fatal outcomes are possible. In young people, the manifestation of TLST may be characterized by a rapid onset and progression of clinical manifestations requiring urgent medical care.
Questions and Answers
- What is severe fever with thrombocytopenia syndrome? TLST is a viral disease caused by an infection that results in high fever and low platelet count.
- What are the main symptoms of TLST? The main symptoms include high fever, muscle pain, skin rashes and bleeding.
- How is TLST diagnosed? Diagnosis is based on clinical findings and laboratory tests such as blood platelet count and serological tests.
- How is TLST treated? Treatment includes supportive care, medications to relieve symptoms, and, in some cases, surgery.
- What is the prognosis for TLST? The prognosis depends on timely treatment and the general health of the patient; without treatment, the likelihood of serious complications is high.
